| 1 |
An investigation of the impact of futility analysis in publicly funded trials |
|
|
| Benjamin GO Sully,Steven A Julious,Jon Nicholl |
|
| Trials. 2014; 15(1): 61 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
How can attrition rates be reduced in cancer drug discovery? |
|
|
| Lucas Moreno,Andrew DJ Pearson |
|
| Expert Opinion on Drug Discovery. 2013; 8(4): 363 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine |
|
|
| Elliott Antman,Scott Weiss,Joseph Loscalzo |
|
| Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine |
|
|
| Antman, E., Weiss, S., Loscalzo, J. |
|
| Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367-383 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Implications of comparative effectiveness research for radiation oncology |
|
|
| Justin E. Bekelman,Anand Shah,Stephen M. Hahn |
|
| Practical Radiation Oncology. 2011; 1(2): 72 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Adaptive trial design: Its growing role in clinical research and implications for pharmacists |
|
|
| Cirulli, J., McMillian, W.D., Saba, M., Stenehjem, D. |
|
| American Journal of Health-System Pharmacy. 2011; 68(9): 807-813 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Adaptive design - an innovative tool in drug development |
|
|
| Brahmachari, B., Bhatt, A. |
|
| Indian Journal of Medical Research. 2011; 133(3): 243-245 |
|
| [Pubmed] [Google Scholar] |
|
